当前位置:首页 - 行情中心 - 九强生物(300406) - 财务分析

九强生物

(300406)

  

流通市值:72.60亿  总市值:101.15亿
流通股本:4.22亿   总股本:5.88亿

九强生物(300406)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2023年年度实现净利润5.22亿元,每股收益0.90元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2023年年度最新股东权益372155.02万元,未分配利润238801.36万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2023年年度最新总资产517574.88万元,负债145419.86万元。

利润表
报告期2023-12-312023-09-302023-06-302023-03-31
营业总收入1,741,626,675.371,233,685,019.6816,327,794.28373,395,954.06
营业总成本1,152,367,616.41808,875,161.23541,125,105.91248,450,721.02
营业利润593,876,387.22421,742,975.59271,770,574.59129,410,405.87
利润总额593,554,564.06421,660,308.1271,675,683.04129,350,301.02
净利润522,069,659.87368,104,602.24239,333,571.71109,943,665.23
其他综合收益218,516.48406,951.97504,177.12-243,119
综合收益总额522,288,176.35368,511,554.21239,837,748.83109,700,546.23
资产负债表
报告期2023-12-312023-09-302023-06-302023-03-31
流动资产合计2,334,266,497.332,347,254,3282,177,654,037.082,111,667,206.36
非流动资产合计2,841,482,308.992,619,345,161.372,619,195,742.662,575,355,956.64
资产总计5,175,748,806.324,966,599,489.374,796,849,779.744,687,023,163
流动负债合计297,115,778.07256,582,677.68230,231,019.26232,195,684.26
非流动负债合计1,157,082,871.611,137,807,505.951,100,697,785.451,077,709,097.17
负债合计1,454,198,649.681,394,390,183.631,330,928,804.711,309,904,781.43
归属于母公司股东权益合计3,724,591,909.763,578,696,714.443,471,430,346.233,381,450,488.45
股东权益合计3,721,550,156.643,572,209,305.743,465,920,975.033,377,118,381.57
负债和股东权益合计5,175,748,806.324,966,599,489.374,796,849,779.744,687,023,163
现金流量表
报告期2023-12-312023-09-302023-06-302023-03-31
经营活动现金流入小计1,805,262,732.031,273,059,634.07799,428,126.74364,421,827.85
经营活动现金流出小计1,220,169,237.56906,123,224.6631,903,439350,718,395.55
经营活动产生的现金流量净额585,093,494.47366,936,409.47167,524,687.7413,703,432.3
投资活动现金流入小计357,085,797.827,169,767.2616,412,386.72,584,325.57
投资活动现金流出小计484,300,542.76254,568,136.08171,393,349.3834,043,057.33
投资活动产生的现金流量净额-127,214,744.94-247,398,368.82-154,980,962.68-31,458,731.76
筹资活动现金流入小计146,884,254.14120,873,921.1655,350,239.8625,099,270.5
筹资活动现金流出小计221,641,455.53178,364,316.06102,431,056.0125,853,205.53
筹资活动产生的现金流量净额-74,757,201.39-57,490,394.9-47,080,816.15-753,935.03
汇率变动对现金及现金等价物的影响196,198.38146,268.89296,201.86-247,826.14
现金及现金等价物净增加额383,317,746.5262,193,914.64-34,240,889.23-18,757,060.63
期末现金及现金等价物余额711,630,480.47390,506,648.59294,071,844.72321,963,005.37
最新报告期:2024-04-04
研究机构分析师预测每股收益(元)更新日
2023年2024年2025年
太平洋谭紫媚1.071.311.602024-04-04
光大证券黎一江1.071.301.562024-03-31
光大证券黎一江0.891.141.422024-02-27
光大证券黎一江1.141.42--2024-02-27
中泰证券谢木青0.871.031.372024-02-25
TOP↑